NCT00283764撤回3 期
A Phase 3, 12-Week, Parallel-Design Study Comparing The Safety, Efficacy, and Ease Of Use Of Xalatan When Self-Administered By Subjects With Open-Angle Glaucoma Or Ocular Hypertension Using Either A Conventional Dropper Bottle Or A Forced-Flow Delivery Device
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.0 个研究点开始时间: 2006年1月30日最近更新:
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 撤回
- 发起方
- 主要终点
- Intra-ocular pressure (IOP) level in the study eye.
研究概览
简要总结
Compare the antihypertensive efficacy of two methods for instilling Xalatan eyedrops
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of primary open angle glaucoma or ocular hypertension in 1 or both eyes
排除标准
- •History of closed/barely open anterior chamber angle or a history of angle closure
结局指标
主要结局
Intra-ocular pressure (IOP) level in the study eye.
次要结局
- Successful eyedrop self-deliveries
- Ease of eyedrop administration
- Change in safety assessments throughout the study period
- Subject preference for the method of drop delivery
研究者
相似试验
撤回
2 期
Corneal Versus Conjunctival Delivery Using a Delivery DeviceGlaucoma, Open-AngleOcular HypertensionNCT00143429Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
已完成
4 期
Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension.Glaucoma, Open-AngleOcular HypertensionNCT00140062Pfizer329
已完成
不适用
Non Interventional Study in Patients With Open Angle Glaucoma and/or Ocular Hypertension Treated With XALATAN®Glaucoma,Open-AngleOcular HypertensionNCT00486252Pfizer's Upjohn has merged with Mylan to form Viatris Inc.996
已完成
4 期
Short Term Comparative Study of Xalatan With Benzalkonium Chloride vs. Travatan Z Without Benzalkonium Chloride in Healthy VolunteersGlaucomaNCT00468988Alcon Research30
已完成
4 期
A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-angle GlaucomaGlaucoma, Open-AngleOcular HypertensionNCT00647101Pfizer's Upjohn has merged with Mylan to form Viatris Inc.600